The role of cardiac fat in insulin resistance

Current Opinion in Clinical Nutrition and Metabolic Care

Volumn 15, Issue 6, 2012, Pages 523-528

  Gastaldelli, Amalia ^a   Morales, Maria A ^a   Marraccini, Paolo ^a   Sicari, Rosa ^a  

^a INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

Author keywords

atherosclerosis; cardiac steatosis; lipotoxicity; mediastinal fat; myocardial insulin resistance

Indexed keywords

DIACYLGLYCEROL; FATTY ACID; GLUCOSE; LONG CHAIN ACYL COENZYME A DEHYDROGENASE; TRIACYLGLYCEROL;

ADIPOSE TISSUE; CARDIAC FAT DEPOSITION; CARDIOMETABOLIC RISK; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; ENERGY METABOLISM; EPICARDIAL ADIPOSE TISSUE; EXTRA PERICARDIAL ADIPOSE TISSUE; GLUCOSE TRANSPORT; HEART DISEASE; HEART MUSCLE METABOLISM; HUMAN; INSULIN RESISTANCE; LIPID STORAGE; LIPOTOXICITY; MAGNETIC RESONANCE IMAGING UNIT; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; REVIEW;

ADIPOKINES; ADIPOSE TISSUE; ANIMALS; ATHEROSCLEROSIS; BODY FAT DISTRIBUTION; DISEASE MODELS, ANIMAL; HUMANS; INSULIN RESISTANCE; INTRA-ABDOMINAL FAT; LIPIDS; MYOCARDIUM;

EID: 84868211942     PISSN: 13631950     EISSN: 14736519     Source Type: Journal    
DOI: 10.1097/MCO.0b013e328358be7b     Document Type: Review

References (51)

1. Gastaldelli A, Basta G. Ectopic fat and cardiovascular disease: what is the link? Nutr Metab Cardiovasc Dis 2010; 20:481-490.
2. Sironi AM, Petz R, De Marchi D, et al. Impact of increased visceral and cardiac fat on cardiometabolic risk and disease. Diabet Med 2012; 29:622-627.
3. Marchington JM, Mattacks CA, Pond CM. Adipose tissue in the mammalian heart and pericardium: structure, foetal development and biochemical properties. Comp Biochem Physiol B 1989; 94:225-232.
4. Gorter PM, van Lindert AS, de Vos AM, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008; 197:896-903.
5. Yudkin JS, Eringa E, Stehouwer CD. Vasocrine' signalling from perivascular fat: a mechanism linking insulin resistance to vascular disease. Lancet 2005; 365:1817-1820.
6. van der Meer RW, Doornbos J, Kozerke S, et al. Metabolic imaging of myocardial triglyceride content: reproducibility of 1H MR spectroscopy with respiratory navigator gating in volunteers. Radiology 2007; 245:251-257.
7. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999; 276:E977-E989.
8. Schejbal V. Epicardial fatty tissue of the right ventricle: morphology, morphometry and functional significance. Pneumologie 1989; 43:490-499.
9. Corradi D, Maestri R, Callegari S, et al. The ventricular epicardial fat is related to the myocardial mass in normal, ischemic and hypertrophic hearts. Cardiovasc Pathol 2004; 13:313-316.
10. Nakazato R, Rajani R, Cheng VY, et al. Weight change modulates epicardial fat burden: a 4-year serial study with noncontrast computed tomography. Atherosclerosis 2012; 220:139-144.
11. Iacobellis G, Singh N, Wharton S, Sharma AM. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) 2008; 16:1693-1697.
12. Willens HJ, Byers P, Chirinos JA, et al. Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography. Am J Cardiol 2007; 99:1242-1245.
13. Hammer S, Snel M, Lamb HJ, et al. Prolonged caloric restriction in obese patients with type 2 diabetes mellitus decreases myocardial triglyceride content and improves myocardial function. J Am Coll Cardiol 2008; 52:1006-1012.
14. Kim MK, Tomita T, Kim MJ, et al. Aerobic exercise training reduces epicardial fat in obese men. J Appl Physiol 2009; 106:5-11.
15. Winhofer Y, Krssak M, Jankovic D, et al. Short-term hyperinsulinemia and hyperglycemia increase myocardial lipid content in normal subjects. Diabetes 2012; 61:1210-1216.
16. Sicari R, Sironi AM, Petz R, et al. Pericardial rather than epicardial fat is a cardiometabolic risk marker: an MRI vs echo study. J Am Soc Echocardiogr 2011; 24:1156-1162.
17. Iacobellis G, Ribaudo MC, Assael F, et al. Echocardiographic epicardial adipose tissue is related to anthropometric and clinical parameters of metabolic syndrome: a new indicator of cardiovascular risk. J Clin Endocrinol Metab 2003; 88:5163-5168.
18. Coppini G, Favilla R, Marraccini P, et al. Quantification of epicardial fat by cardiac CT imaging. Open Med Inform J 2010; 4:126-135.
19. Nelson AJ, Worthley MI, Psaltis PJ, et al. Validation of cardiovascular magnetic resonance assessment of pericardial adipose tissue volume. J Cardiovasc Magn Reson 2009; 11:15.
20. Smith-Bindman R, Miglioretti DL, Johnson E, et al. Use of diagnostic imaging studies and associated radiation exposure for patients enrolled in large integrated healthcare systems, 1996-2010 diagnostic imaging and radiation exposure. JAMA 2012; 307:2400-2409.
21. Picano E, Vano E. The radiation issue in cardiology: the time for action is now. Cardiovasc Ultrasound 2011; 9:35.
22. Iacobellis G, Pond CM, Sharma AM. Different 'weight' of cardiac and general adiposity in predicting left ventricle morphology. Obesity (Silver Spring) 2006; 14:1679-1684.
23. Kellman P, Hernando D, Arai AE. Myocardial fat imaging. Curr Cardiovasc Imaging Rep 2010; 3:83-91.
24. Sironi AM, Pingitore A, Ghione S, et al. Early hypertension is associated with reduced regional cardiac function, insulin resistance, epicardial, and visceral fat. Hypertension 2008; 51:282-288.
25. Rosito GA, Massaro JM, Hoffmann U, et al. Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation 2008; 117:605-613.
26. Iozzo P, Lautamaki R, Borra R, et al. Contribution of glucose tolerance and gender to cardiac adiposity. J Clin Endocrinol Metab 2009; 94:4472-4482.
27. Sironi AM, Gastaldelli A, Mari A, et al. Visceral fat in hypertension: influence on insulin resistance and beta-cell function. Hypertension 2004; 44:127-133.
28. Iacobellis G, Leonetti F. Epicardial adipose tissue and insulin resistance in obese subjects. J Clin Endocrinol Metab 2005; 90:6300-6302.
29. Gaborit B, Kober F, Jacquier A, et al. Assessment of epicardial fat volume and myocardial triglyceride content in severely obese subjects: relationship to metabolic profile, cardiac function and visceral fat. Int J Obes (Lond) 2012; 36:422-430.
30. Perseghin G, Lattuada G, De Cobelli F, et al. Increased mediastinal fat and impaired left ventricular energy metabolism in young men with newly found fatty liver. Hepatology 2008; 47:51-58.
31. McGavock JM, Lingvay I, Zib I, et al. Cardiac steatosis in diabetes mellitus: a 1H-magnetic resonance spectroscopy study. Circulation 2007; 116:1170-1175.
32. Ferrannini E, Iozzo P. Is insulin resistance atherogenic? A review of the evidence. Atheroscler Suppl 2006; 7:5-10.
33. Kankaanpaa M, Lehto HR, Parkka JP, et al. Myocardial triglyceride content and epicardial fat mass in human obesity: relationship to left ventricular function and serum free fatty acid levels. J Clin Endocrinol Metab 2006; 91:4689-4695.
34. Rijzewijk LJ, Jonker JT, van der Meer RW, et al. Effects of hepatic triglyceride content on myocardial metabolism in type 2 diabetes. J Am Coll Cardiol 2010; 56:225-233.
35. Gorter PM, de Vos AM, van der Graaf Y, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008; 102:380-385.
36. Iozzo P, Chareonthaitawee P, Dutka D, et al. Independent association of type 2 diabetes and coronary artery disease with myocardial insulin resistance. Diabetes 2002; 51:3020-3024.
37. Bugger H, Abel ED. Mitochondria in the diabetic heart. Cardiovasc Res 2010; 88:229-240.
38. Christoffersen C, Bollano E, Lindegaard ML, et al. Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003; 144:3483-3490.
39. Duncan JG. Mitochondrial dysfunction in diabetic cardiomyopathy. Biochim Biophys Acta 2011; 1813:1351-1359.
40. Gastaldelli A, Natali A, Vettor R, Corradini SG. Insulin resistance, adipose depots and gut: interactions and pathological implications. Dig Liver Dis 2010; 42:310-319.
41. Brindley DN, Kok BP, Kienesberger PC, et al. Shedding light on the enigma of myocardial lipotoxicity: the involvement of known and putative regulators of fatty acid storage and mobilization. Am J Physiol Endocrinol Metab 2010; 298:E897-E908.
42. Szendroedi J, Roden M. Ectopic lipids and organ function. Curr Opin Lipidol 2009; 20:50-56.
43. Taegtmeyer H, Razeghi P. Heart disease in diabetes: resist the beginnings. J Am Coll Cardiol 2004; 43:315; author reply 315.
44. Abel ED. Myocardial insulin resistance and cardiac complications of diabetes. Curr Drug Targets Immune Endocr Metabol Disord 2005; 5:219-226.
45. Guzik TJ, Marvar PJ, Czesnikiewicz-Guzik M, Korbut R. Perivascular adipose tissue as a messenger of the brain-vessel axis: role in vascular inflammation and dysfunction. J Physiol Pharmacol 2007; 58:591-610.
46. Baker AR, Silva NF, Quinn DW, et al. Human epicardial adipose tissue expresses a pathogenic profile of adipocytokines in patients with cardiovascular disease. Cardiovasc Diabetol 2006; 5:1.
47. Sacks HS, Fain JN. Human epicardial adipose tissue: a review. Am Heart J 2007; 153:907-917.
48. Sarin S, Wenger C, Marwaha A, et al. Clinical significance of epicardial fat measured using cardiac multislice computed tomography. Am J Cardiol 2008; 102:767-771.
49. Iacobellis G, Barbaro G. The double role of epicardial adipose tissue as proand anti-inflammatory organ. Horm Metab Res 2008; 40:442-445.
50. Gustafson B. Adipose tissue, inflammation and atherosclerosis. J Atheroscler Thromb 2010; 17:332-341.
51. Torres-Leal FL, Fonseca-Alaniz MH, Rogero MM, Tirapegui J. The role of inflamed adipose tissue in the insulin resistance. Cell Biochem Funct 2010; 28:623-631.